Hydrocephalus Shunts - Market Insights, Competitive Landscape, and Market Forecast - 2030

The market is expected to advance at a respectable CAGR forecast till 2028 owing to the rising prevalence of brain and neurological disorders and growing use of sophisticated programmable valves across the globe.

The global hydrocephalus shunts market will grow at a CAGR of 4.33% during the forecast period from 2023 to 2028. The hydrocephalus shunts market is observing significant market growth primarily owing to the mounting figures of various brain and neurological disorders. Further, an increase in the geriatric population base, increasing adoption of advanced programmable valves, increasing product launches and approvals, surging investments by key players, and others will ultimately affect the demand for hydrocephalus shunts certainly during the forecast period. In addition, increasing awareness regarding hydrocephalus, and increasing numbers of brain injuries, traumatic injuries, and hemorrhagic stroke will affect the market of hydrocephalus shunts significantly. Therefore, the market of hydrocephalus shunts is estimated to grow at a substantial CAGR during the forecast period from 2023 to 2028.

Hydrocephalus Shunts Market Dynamics:

According to the latest Traumatic Brain Injury Fact Sheets and Policy Brief, nearly 50 million people suffer from traumatic brain injury (TBI), worldwide, every year. In developing countries, TBI increasingly affects the elderly and children under 4 years old. As per the same source, 1.5 million patients are hospitalized every year due to TBI, in Europe.

According to the Center for Disease Control and Prevention (CDC), in the United States, around 80,000 to 90,000 people each year are disabled due to TBI.

In addition, neurosurgeons are inclined toward the latest technology shunts, antisiphon devices, and advanced programmable valves. Antisiphon devices help in avoiding siphon effects over cerebrospinal fluid. Thus, the increasing demand for antisiphon devices will ultimately lead to the increased demand for hydrocephalus shunts in the market.

Moreover, the introduction of cutting-edge equipment that can be used efficiently in healthcare institutes with the inferior system and facilities, increasing funding for R&D by the concerned organization due to the emergence of several types of new pathogens, and surging number of manufacturers engaged in the strategic creation of new items, will drive the growth of hydrocephalus shunts in the market during the forecast period.

Therefore, the factors stated above collectively will drive the overall hydrocephalus shunts market during the forecast period from 2023-2028.

However, the high cost of the treatments involving shunts, shunt malfunction, shunt infection, and others may prove to be challenging factors for the hydrocephalus shunt market growth.

The hydrocephalus shunts market was significantly impacted during the period of the COVID-19 pandemic. During the initial stage of the pandemic, the demand for hydrocephalus shunts suffered a disgrace owing to the imposition of strict lockdown rules, and disruption in manufacturing, and supply. Moreover, due to the diversion of the medical field towards COVID-19, the funding for R&D activities related to neurological and brain disorders was either halted or postponed and many non-urgent surgeries were also postponed, thereby declining the demand for hydrocephalus shunts in the market. However, with the ease of lockdown restrictions, the upturn of resources and supply chain, the administration of a vaccine to the public, and the return of patients to hospitals for surgeries, the demand for hydrocephalus shunts increased and is anticipated to drive the market growth.

Hydrocephalus Shunts Market Segment Analysis:

Hydrocephalus Shunts Market by Product (Hydrocephalus Valves [Adjustable Pressure Valves And Fix Pressure Valves], Hydrocephalus Catheters, and Others), Age Group (Paediatric and Adults), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the hydrocephalus shunts market, the hydrocephalus catheters segment is expected to have a significant revenue share in the year 2022. This was primarily owing to the applications offered by the segment and the rising product launches and approvals in the market.

For instance, these hydrocephalus catheters are an important part for managing hydrocephalus, as certain patient populations are at greater risk of developing shunt infections. The proximal catheter also known as ventricular or lumbar catheter drains excess cerebrospinal fluid (CSF) from the ventricles or lumbar spinal sac via rows of small holes at its tip, whereas the distal catheters are usually inserted into the abdominal cavity. They can be implanted in the heart, pleural cavity (lungs), and other suitable locations where CSF is drained into the bloodstream.

Furthermore, the various technological advancements in these devices to combat biocompatibility, infection, and fouling are expected to drive segment growth during the forecast period. Some shunt catheters, such as the CODMAN BACTISEAL catheter and the Medtronic Ares catheter, are impregnated with antibiotics to reduce the risk of infection during the postoperative period. Antibiotic-impregnated Ares catheters aid in the reduction of bacterial colonization.

The current focus of research is on the potential to redesign hydrocephalus catheters, which could boost the segment's growth. For instance, MIT researchers published a paper in the Journal of the Royal Society Interface in 2020 that proposes and validates a new design principle for hydrocephalus catheters. The design aims to address a major issue with these devices, which is that they frequently become clogged. The new design principle has the potential to prevent catheter failure in brain shunts.

Therefore, owing to the above-mentioned applications, the demand for hydrocephalus catheters is expected to witness considerable growth eventually contributing to the overall growth of the global hydrocephalus shunts market during the forecast period from 2023-2028.

North America is expected to dominate the overall Hydrocephalus Shunts Market:

Among all the regions, North America is expected to dominate global hydrocephalus shunts in the year 2022 and is expected to do the same during the forecast period from 2023-2028.

This can be ascribed to the rising product launches from the hydrocephalus shunt manufacturers in the US, the rising burden of the geriatric population prone to neurological and brain disorders, high awareness among the people about hydrocephalus and other neurological disorders, favorable reimbursement scenarios, and others act as a supportive factor for the North America hydrocephalus shunts market growth.

The Centers for Disease Control and Prevention (CDC) in 2022, mentioned that there were approximately 223,135 TBI-related hospitalizations in 2019 and 64,362 TBI-related deaths in 2020. This represents more than 611 TBI-related hospitalizations and 176 TBI-related deaths per day, in the United States.

Further, as per the National Institute of Neurological Disorders and Stroke (2019), in 2019, an estimated 1 million people in the United States were affected by hydrocephalus, and 1 in every 1,000 babies had hydrocephalus, in the United States.

In addition, the rising burden of the geriatric population, the high prevalence of brain and neurological disorders, and the increasing adoption of advanced programmable valves are all contributing to the market's growth in the United States, ultimately the demand for these products is expected to be driven by the disease's large population base.

Increasing product launches and approvals in the region will also affect the market positively. For instance, in February 2022, CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, received the U.S. Food and Drug Administration (FDA) approval of an investigational device exemption (IDE) application to initiate a pilot trial of the eShunt System in patients with normal pressure hydrocephalus (NPH). Also, in August 2022, CereVasc, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial of the eShunt System in patients who develop communicating hydrocephalus post aneurysmal subarachnoid hemorrhage (paSAH).

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the hydrocephalus shunts market.

Hydrocephalus Shunts Market Key Players:

Some of the key market players operating in the hydrocephalus shunts market include B. Braun SE (Christoph Miethke GmbH & Co. KG), Johnson & Johnson, Integra LifeSciences, Spiegelberg GmbH & Co. KG., Medtronic, Sophysa, TKB Corporation, G.SURGIWEAR LTD., HpBio Próteses, inc., Kaneka Medix Corp., Natus Medical Incorporated., Desu Medical, HLL Lifecare, Anuncia Inc., Fuji Systems, and others.

Recent Developmental Activities in the Hydrocephalus Shunts Market:

• In September 2022, Anuncia Medical, Inc., announced the U.S. Food and Drug Administration (FDA) clearance of ReFlow® System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid (CSF) disorders that require shunting.
• In May 2020, Aesculap, Inc., in partnership with The Christoph Miethke GmbH & Co. KG (MIETHKE), launched M.blue valve, the latest generation of hydrocephalus valve technology. Its unique gravitational technology is integrated with a fixed differential pressure unit in one valve, allowing for a simple, position-dependent solution.

Key Takeaways from the Hydrocephalus Shunts Market Report Study

• Market size analysis for current hydrocephalus shunts market size (2022), and market forecast for 5 years (2023-2028)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the hydrocephalus shunts market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global hydrocephalus shunt market.
• Various opportunities are available for the other competitor in the hydrocephalus shunts market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028?
• Which are the top-performing regions and countries in the current hydrocephalus shunts market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for hydrocephalus shunts market growth in the coming future?

Target Audience who can be benefited from this Hydrocephalus Shunts Market Report Study

• Hydrocephalus shunts products providers
• Research organizations and consulting companies
• Hydrocephalus shunts- related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in hydrocephalus shunts
• Various end users who want to know more about the hydrocephalus shunts market and the latest technological developments in the hydrocephalus shunts market.

Frequently Asked Questions for the Hydrocephalus Shunts Market:

1. What are hydrocephalus shunts?

Hydrocephalus shunt is a medical device that helps treat a condition in the brain in which excessive accumulation of cerebrospinal fluid occurs, resulting in increased intracranial pressure within the skull. These devices relieve pressure on the brain caused by fluid accumulation.

2. What is the global market for hydrocephalus shunts?

The global hydrocephalus shunts market will grow at a CAGR of 4.33% during the forecast period from 2023 to 2028.

3. What are the drivers for the global hydrocephalus shunts market?

The hydrocephalus shunts market is witnessing positive market growth owing to the factors such as the increasing prevalence of hydrocephalus, growing use of sophisticated programmable valves, surging burden of the geriatric population, increasing product launches and approvals, and others will create an exigency for the hydrocephalus shunts market.

4. Who are the key players operating in the global hydrocephalus shunts market?

Some of the key market players operating in the hydrocephalus shunts market include B. Braun SE (Christoph Miethke GmbH & Co. KG), Johnson & Johnson, Integra LifeSciences, Spiegelberg GmbH & Co. KG., Medtronic, Sophysa, TKB Corporation, G.SURGIWEAR LTD., HpBio Próteses, inc., Kaneka Medix Corp., Natus Medical Incorporated., Desu Medical, HLL Lifecare, Anuncia Inc., Fuji Systems, and others.

5. Which region has the highest share of the hydrocephalus shunts catheter market?

Among all the regions, North America is estimated to amass a significant revenue share in the global hydrocephalus shunts market. This can be ascribed to the rising product launches from the hydrocephalus shunt manufacturers in the US, the rising burden of the geriatric population prone to neurological and brain disorders, high awareness among the people about hydrocephalus and other neurological disorders, favorable reimbursement scenarios, and others act as a supportive factor for the North America hydrocephalus shunts market growth.